EP 1673389 A2 20060628 - NOVEL VARIANTS OF CD40L PROTEIN
Title (en)
NOVEL VARIANTS OF CD40L PROTEIN
Title (de)
VARIANTEN DES CD40L-PROTEINS
Title (fr)
NOUVEAUX VARIANTS DE LA PROTEINE CD40L
Publication
Application
Priority
- US 2004033707 W 20041012
- US 51043003 P 20031010
- US 51772803 P 20031105
- US 52354503 P 20031120
Abstract (en)
[origin: WO2005035570A2] The present invention relates to soluble, recombinant CD40L variant proteins that may be expressed solubly in E. coli. The variants of the present invention may substantially reduced binding to alpha IIb-beta3 integrin, act as CD40L antagonists or agonists, and methods for generating the same.
IPC 1-7
IPC 8 full level
C07K 14/705 (2006.01)
CPC (source: EP)
C07K 14/70575 (2013.01)
Citation (search report)
See references of WO 2005035570A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005035570 A2 20050421; WO 2005035570 A3 20051103; EP 1673389 A2 20060628
DOCDB simple family (application)
US 2004033707 W 20041012; EP 04794935 A 20041012